申请人:Johnson Stephen Patrick
公开号:US20070249585A1
公开(公告)日:2007-10-25
Compounds of formula (I),
or pharmaceutically acceptable derivatives thereof, wherein
R represents H, C
1-6
alkyl, SO
2
R
1
, SO
2
NR
1
R
2
, or COR
1
;
R
1
and R
2
independently represent C
1-6
alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; may be useful in the treatment of anxiety, cardiovascular disease (including angina, atherosclerosis, hypertension, heart failure, edema, hypernatremia), dysmenorrhoea (primary and secondary), endometriosis, emesis (including motion sickness), intrauterine growth retardation, inflammation (including rheumatoid arthritis), mittlesmerchz, preclampsia, premature ejaculation, premature (preterm) labor and Raynaud's disease.
公式(I)的化合物或其药学上可接受的衍生物,其中R代表氢,C1-6烷基,SO2R1,SO2NR1R2或COR1; R1和R2独立地表示C1-6烷基; 环A表示苯环或吡啶环; 可能在焦虑症、心血管疾病(包括心绞痛、动脉粥样硬化、高血压、心力衰竭、水肿、高血钠症)、痛经(原发性和继发性)、子宫内膜异位症、恶心(包括晕动病)、宫内生长迟缓、炎症(包括类风湿性关节炎)、中间痛、子痫前期、早泄、早产和雷诺病的治疗中有用。